stockrow
Friday 6 November 2026
Export PHVS’s income statement to Excel — free account
Pharvaris N.V.
PHVS Healthcare Biotechnology
- EPS
- +13.8%
- Free cash flow
- −17.3%
- Total debt
- +4.31%
Quarter to June 2026, against a year earlier
34.75
2.22
+6.82%
Follow PHVS
Alert me
Pharvaris N.V. (PHVS) Book value per share
Pharvaris N.V.'s book value per share at the end of fiscal 2025 was 5.2×, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was 5.1×. Over the past ten years it has ranged from 1.2× (fiscal 2018) to 22.6× (fiscal 2020); the current reading is higher than 50% of that period. Pharvaris N.V. ranks 152nd of 611 Biotechnology companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 5.2× | (3.27%) |
| FY2024 | 5.4× | (50.46%) |
| FY2023 | 10.8× | 131.22% |
| FY2022 | 4.7× | (41.27%) |
| FY2021 | 8.0× | (64.66%) |
| FY2020 | 22.6× | 421.99% |
| FY2019 | 4.3× | 270.22% |
| FY2018 | 1.2× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 5.1× | 21.30% |
| Mar 2026 | 4.2× | (18.36%) |
| Dec 2025 | 5.2× | (11.51%) |
| Sep 2025 | 5.9× | 53.21% |
| 20 more quarters | Free account |
Against its own ten years
Low 1.2×
High 22.6×
Ten-year median
5.3×
Current reading's percentile
50
Book value per share against peers
| Company | Book value per share |
|---|---|
| PVLA Palvella Therapeutics, Inc. compare | 15.1× |
| CLDX Celldex Therapeutics, Inc. compare | 9.2× |
| VCEL Vericel Corporation compare | 7.5× |
| PHVS Pharvaris N.V. | 5.1× |
| NAMS NewAmsterdam Pharma Company N.V. compare | 5.1× |
| IMNM Immunome, Inc. compare | 4.6× |
| ADMA ADMA Biologics Inc compare | 2.0× |
| RXRX Recursion Pharmaceuticals, Inc. compare | 1.7× |
| BHVN Biohaven Ltd. compare | −0.7× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))